SPY319.34+8.04 2.58%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

Altimmune Q1 EPS $(0.260) Beats $(0.320) Estimate, Sales $2.200M Beat $500.000K Estimate

Altimmune (NASDAQ:ALT) reported quarterly losses of $(0.260) per share which beat the analyst consensus estimate of $(0.320) by 18.75 percent. This is a 3.7 percent increase over losses of $(0.270) per share from the

Benzinga · 05/13/2020 21:54

Altimmune (NASDAQ:ALT) reported quarterly losses of $(0.260) per share which beat the analyst consensus estimate of $(0.320) by 18.75 percent. This is a 3.7 percent increase over losses of $(0.270) per share from the same period last year. The company reported quarterly sales of $2.200 million which beat the analyst consensus estimate of $500.000 thousand by 340.00 percent. This is a 25.58 percent decrease over sales of $2.956 million the same period last year.